Corbevax is safe, will be administered in two doses, says NTAGI chief

The antibody level of the Corbe vax Covid-19 vaccine is very high and overall it is a very useful vaccine, says Dr NK Arora, Chairman of Covid-19 Working Group of NTAGI.

New Delhi: Chairman of Covid-19 Working Group of NTAGI, Dr NK Arora on Tuesday (February 15) said that the  Covid-19 vaccine Corbevax is a safe vaccine and will be administered with two doses like other vaccines.

"Corbevax is a safe vaccine and local reactions are also less. The antibody level of this vaccine is also very high. Overall Corbevax is a very useful vaccine. It will have 2 primary doses just like other vaccines in India," told Dr Arora to ANI.

This comes after India`s apex drug regulatory body Drugs Controller General of India`s Subject Expert Committee on Monday (February 14) granted the restricted emergency use authorisation to Biological E`s Covid vaccine Corbevax for adolescents in the 12 to 18 years age bracket. However, the approval is subject to certain conditions, said a source familiar with the development.

(With agency inputs)